HEPCINAT 400MG TAB 28S

About

HEPCINAT 400MG TAB 28S contains Sofosbuvir, a direct-acting antiviral agent specifically designed for the treatment of chronic hepatitis C virus (HCV) infection. Sofosbuvir is a nucleotide analog prodrug that, once metabolized, inhibits the HCV NS5B RNA-dependent RNA polymerase, an enzyme essential for viral replication. By targeting this crucial enzyme, Sofosbuvir effectively blocks the virus from making copies of itself, leading to a significant reduction in viral load and, in many cases, a sustained virologic response (SVR), which is considered a cure. This medication is typically used in combination with other antiviral agents, such as ribavirin or other direct-acting antivirals, depending on the HCV genotype and the patient's clinical status. Its high efficacy and favorable safety profile have revolutionized HCV treatment, offering a shorter and more tolerable treatment regimen compared to older interferon-based therapies.

Uses

• Treatment of chronic hepatitis C virus (HCV) infection.
• Used in combination with other antiviral agents.
• Effective across various HCV genotypes.
• Aims for sustained virologic response (SVR).

Directions For Use

Take one tablet orally once daily with or without food. It is crucial to take this medication exactly as prescribed by your doctor.

Benefits

• Highly effective against chronic HCV infection.
• Leads to high rates of sustained virologic response (SVR).
• Offers a shorter treatment duration compared to older therapies.
• Generally well-tolerated with a favorable safety profile.
• Can be used in various HCV genotypes.
• Significantly reduces the risk of HCV-related complications.

Side Effects

• Fatigue
• Headache
• Nausea
• Insomnia
• Diarrhea
• Anemia (especially with ribavirin)
• Irritability
• Rash
• Pruritus
• Dyspnea
• Decreased appetite
• Muscle pain

Safety Measures

• Alcohol - Alcohol can worsen liver damage in HCV patients and may interfere with treatment efficacy. Complete abstinence from alcohol is strongly recommended during treatment.
• Pregnancy - Not recommended during pregnancy due to potential risks, especially when used with ribavirin, which is highly teratogenic. Effective contraception is essential.
• Breastfeeding - It is unknown if Sofosbuvir passes into breast milk. Due to potential risks to the infant, breastfeeding is generally not recommended during treatment.
• Liver - This medication is for liver disease. While generally safe, patients with decompensated cirrhosis require careful monitoring and specific combination regimens.
• Kidney - Patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²) or end-stage renal disease requiring dialysis should use with caution, as data are limited.
• Lung - No specific contraindications or precautions related to lung conditions are generally noted for Sofosbuvir.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.